Literature DB >> 19501006

A rubber-degrading organism growing from a human body.

Mohit Gupta1, Deepali Prasad, Harshit S Khara, David Alcid.   

Abstract

Patients with hematological malignancies are susceptible to unusual infections, because of the use of broad-spectrum anti-infective agents, invasive procedures, and other immunocompromising procedures and medications. Gordonia polyisoprenivorans, a ubiquitous environmental aerobic actinomycete belonging to the family of Gordoniaceae in the order Actinomycetales, is a very rare cause of bacteremia in these patients. We report the first case of pneumonia with associated bacteremia due to this organism, which was initially described in 1999 as a rubber-degrading bacterium following isolation from stagnant water inside a deteriorated automobile tire. We believe that hematologically immunocompromised patients on broad-spectrum antibiotics and with long-term central catheters select the possibility of infection with G. polyisoprenivorans. These infections can be prevented by handling catheters under aseptic conditions. We propose that blood cultures of persistently febrile neutropenic patients should be incubated for at least 4 weeks. Being a rare infection, there are no data available on treatment other than early removal of the foreign bodies. Copyright 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19501006     DOI: 10.1016/j.ijid.2009.03.006

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  8 in total

Review 1.  Gordonia bronchialis bacteremia and pleural infection: case report and review of the literature.

Authors:  Jennifer A Johnson; Andrew B Onderdonk; Lisa A Cosimi; Sigal Yawetz; Brent A Lasker; Shanna J Bolcen; June M Brown; Francisco M Marty
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

2.  Pattern of antimicrobial susceptibility obtained from blood isolates of a rare but emerging human pathogen, Gordonia polyisoprenivorans.

Authors:  Benjamin D Moser; Gerald J Pellegrini; Brent A Lasker; June M Brown
Journal:  Antimicrob Agents Chemother       Date:  2012-07-02       Impact factor: 5.191

3.  Gordonia species as emerging causes of continuous-ambulatory-peritoneal-dialysis-related peritonitis identified by 16S rRNA and secA1 gene sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS).

Authors:  Jimmy Y W Lam; Alan K L Wu; Wai-Shing Leung; Ingrid Cheung; Chi-Ching Tsang; Jonathan H K Chen; Jasper F W Chan; Cindy W S Tse; Rodney A Lee; Susanna K P Lau; Patrick C Y Woo
Journal:  J Clin Microbiol       Date:  2014-11-26       Impact factor: 5.948

Review 4.  Gordonia: isolation and identification in clinical samples and role in biotechnology.

Authors:  Fatemeh Andalibi; Mehdi Fatahi-Bafghi
Journal:  Folia Microbiol (Praha)       Date:  2017-01-20       Impact factor: 2.099

5.  Gordonia bacteremia.

Authors:  Poornima Ramanan; Paul J Deziel; Nancy L Wengenack
Journal:  J Clin Microbiol       Date:  2013-07-24       Impact factor: 5.948

6.  Involvement of two latex-clearing proteins during rubber degradation and insights into the subsequent degradation pathway revealed by the genome sequence of Gordonia polyisoprenivorans strain VH2.

Authors:  Sebastian Hiessl; Jörg Schuldes; Andrea Thürmer; Tobias Halbsguth; Daniel Bröker; Angel Angelov; Wolfgang Liebl; Rolf Daniel; Alexander Steinbüchel
Journal:  Appl Environ Microbiol       Date:  2012-02-10       Impact factor: 4.792

Review 7.  Bacteremia due to Gordonia polyisoprenivorans: case report and review of literature.

Authors:  Xiurong Ding; Yanhua Yu; Ming Chen; Chen Wang; Yanfang Kang; Hongman Li; Jinli Lou
Journal:  BMC Infect Dis       Date:  2017-06-12       Impact factor: 3.090

8.  An atlas of the tissue and blood metagenome in cancer reveals novel links between bacteria, viruses and cancer.

Authors:  Sven Borchmann
Journal:  Microbiome       Date:  2021-04-22       Impact factor: 14.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.